Stream 5: Diabetes Complications including Late Breaking Abstracts #7
Tracks
Meeting Room 103
| Friday, August 21, 2026 |
| 8:30 AM - 10:30 AM |
Speaker
Sarah Glastras
Chairperson
Biography
Mrs Emily-Jane Sharpington-Recny
Medical Advisor
Medical Advisor
Mechanistic kidney effects of semaglutide by baseline SGLT2i use in type 2 diabetes: A post-hoc analysis of the REMODEL trial
8:30 AM - 8:45 AMBiography
Professor Mark Cooper AO is a recognised endocrinologist and diabetes researcher based in Melbourne, Australia. He is Professor of Medicine and Head of Diabetes at Monash University, and Chief Scientific Officer of Baker Heart and Diabetes Institute. His research focuses on diabetes complications including kidney disease, cardiovascular disease, and retinopathy.
Miss Huishu Julia Lin
Phd Student
Dr Catherine Willis
Advanced Trainee Registrar
Sir Charles Gairdner Hospital
Same service, different outcomes: comparing type 1 and type 2 diabetes in a multidisciplinary diabetic foot service
9:00 AM - 9:15 AMBiography
Dr Cate Willis is an Endocrinology and General Medicine Advanced trainee at Sir Charles Gairdner Hospital in WA, and is currently completing a Master of Human Nutrition at Deakin University. Her interests include women’s health, diabetes, and the role of diet and nutrition in chronic disease management and preventive health.
Prof Ronald Ma
Professor
The Chinese University of Hong Kong
Asia-Pacific expert consensus on NT-proBNP for cardiovascular and kidney risk assessment in people with diabetes: who to test, when to test, and how to interpret
9:15 AM - 9:30 AMBiography
Professor Ronald Ma is Professor and Head of Endocrinology and Diabetes, the Chinese University of Hong Kong. His research focuses on the epidemiology and genetics of diabetes and diabetic complications. Professor Ma has published extensively with H-index of 86 and co-led the Precision Medicine in Diabetes Initiative precision prognosis workgroup.
Dr Xinjun Jiang
Associate Research Fellow
Hainan Medical University
A multidimensional nomogram for early risk stratification of probable cognitive impairment in adults with Type 2 diabetes: A multicenter study
9:30 AM - 9:45 AMBiography
Dr Xinjun Jiang holds a PhD in Nursing from Peking University and is an associate professor and master’s supervisor at Hainan Medical University. A visiting scholar at the National University of Singapore, her research focuses on chronic disease management, digital nursing, health economic evaluation, and nursing education.
Dr Chen Qi
Southwest Medical University Affiliated Hospital
Resolvin D2 promotes diabetic wound healing by reprogramming macrophage polarization via GPR18/TNF/p65 signaling
9:45 AM - 10:00 AMBiography
Dr. Qi Chen, PhD, Associate Chief Nurse and Master’s Supervisor. She is active in national and provincial diabetes nursing and AI committees, with U.S. visiting experience. She has hosted 13 projects, published 15 SCI papers, obtained 10 patents, and won national and provincial medical science and technology awards.
Peishan Li
Doctor
Beijing Hospital / National Center of Gerontology / Chinese Academy of Medical Sciences / Peking Union Medical College
Associations of combined modifiable risk factor control with incident lower-limb ulceration and population-attributable burden in diabetes: A prospective UK Biobank study
10:00 AM - 10:15 AMBiography
Li Peishan is a PhD student in Endocrinology and Metabolism at the Chinese Academy of Medical Sciences & Peking Union Medical College, supervised by Prof. Qi Pan at Beijing Hospital. Her research focuses on diabetic complications. She has published multiple papers in international peer-reviewed journals.
Fei Yan Shi
Master's Student
West China Hospital / Sichuan University
Association of diabetic foot ulcer with increased non-calcified plaque volume and high-risk coronary features in Type 2 Diabetes mellitus
10:15 AM - 10:30 AMBiography
Shi Feiyan is a postgraduate student working under the supervision of Professor Ran Xingwu. Her research focuses on diabetic foot ulcers and their systemic cardiovascular complications, utilizing advanced imaging techniques to explore atherosclerosis in type 2 diabetes.
